Skip to main content
Biomind Labs logo

Biomind Labs — Investor Relations & Filings

Ticker · BMND LEI · 254900YBPPG0XSZOE887 NEO Professional, scientific and technical activities
Filings indexed 196 across all filing types
Latest filing 2021-11-15 Regulatory Filings
Country CA Canada
Listing NEO BMND

About Biomind Labs

https://www.biomindlabs.com/

Biomind Labs is a biotechnology research and development company focused on creating novel pharmaceutical drugs for patients suffering from neurological and psychiatric disorders. The company employs an R&D acceleration platform to develop next-generation formulations, including those based on key endogenous substances. A core technological focus is the integration of nanotech delivery systems to target the underlying drivers of disease.

Recent filings

Filing Released Lang Actions
Interim financial statements/report – English.pdf
Regulatory Filings
2021-11-15 English
NI 44-101 Notice of intent to qualify – English.pdf
Regulatory Filings
2021-10-21 English
Letter from successor auditor.pdf
Regulatory Filings
2021-09-21 English
Letter from former auditor.pdf
Regulatory Filings
2021-09-21 English
Notice.pdf
Regulatory Filings
2021-09-21 English
News release - English.pdf
Regulatory Filings
2021-08-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.